Ads

 

Ads

 

Ads

 

World Top 100 HealthCare Products Companies List by Market Cap in January 2024

World Top 100 HealthCare Products Companies List by Market Cap in January 2024, World Biggest 100 HealthCare Products Companies by Market Cap, World Largest 100 HealthCare Products Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Largest HealthCare Products Companies in 2024
Metatag Abstract
World Top HealthCare Products Companies by Market Cap in 2024, World Largest HealthCare Products Companies by Market Cap in 2024.
  1. JW Pharmaceutical Corporation

    World Rank (Jan-05-2024)
    10,985
    Market Cap (Jan-05-2024)
    0.651 Billion USD
    World Rank (Jul-30-2023)
    11,123
    Market Cap (Jul-30-2023)
    0.647 Billion USD
    World Rank (Dec-25-2022)
    10,614
    Market Cap (Dec-25-2022)
    0.667 Billion USD
    World Rank (Jan-07-2022)
    11,501
    Market Cap (Jan-07-2022)
    0.69 Billion USD
    Annual Revenue in USD
    454 Million USD
    Annual Net Income in USD
    -1 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    JW Pharmaceutical Corporation is a Pharmaceutical company found the market for domestic therapeutic drug. The headquarters is in South Korea.

  2. Guizhou Yibai Pharmaceutical

    World Rank (Jan-05-2024)
    11,077
    Market Cap (Jan-05-2024)
    0.641 Billion USD
    World Rank (Jul-30-2023)
    11,675
    Market Cap (Jul-30-2023)
    0.592 Billion USD
    World Rank (Dec-25-2022)
    10,603
    Market Cap (Dec-25-2022)
    0.668 Billion USD
    World Rank (Jan-07-2022)
    9,683
    Market Cap (Jan-07-2022)
    0.96 Billion USD
    Headquarters Country
  3. Kunming Longjin Pharmaceutical

    World Rank (Jan-05-2024)
    11,164
    Market Cap (Jan-05-2024)
    0.633 Billion USD
    World Rank (Jul-30-2023)
    12,404
    Market Cap (Jul-30-2023)
    0.527 Billion USD
    World Rank (Dec-25-2022)
    10,401
    Market Cap (Dec-25-2022)
    0.694 Billion USD
    World Rank (Jan-07-2022)
    8,886
    Market Cap (Jan-07-2022)
    1.11 Billion USD
    Headquarters Country
  4. Wave Life Sciences

    World Rank (Jan-05-2024)
    11,188
    Market Cap (Jan-05-2024)
    0.631 Billion USD
    World Rank (Jul-30-2023)
    14,083
    Market Cap (Jul-30-2023)
    0.403 Billion USD
    World Rank (Dec-25-2022)
    11,621
    Market Cap (Dec-25-2022)
    0.566 Billion USD
    World Rank (Jan-07-2022)
    19,803
    Market Cap (Jan-07-2022)
    0.17 Billion USD
    Annual Revenue in USD
    40 Million USD
    Annual Net Income in USD
    -122 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Stock Category
  5. MacroGenics Inc.

    World Rank (Jan-05-2024)
    11,264
    Market Cap (Jan-05-2024)
    0.623 Billion USD
    World Rank (Jul-30-2023)
    16,045
    Market Cap (Jul-30-2023)
    0.289 Billion USD
    World Rank (Dec-25-2022)
    14,480
    Market Cap (Dec-25-2022)
    0.365 Billion USD
    World Rank (Jan-07-2022)
    9,924
    Market Cap (Jan-07-2022)
    0.91 Billion USD
    Annual Revenue in USD
    75 Million USD
    Annual Net Income in USD
    -202 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    MacroGenics is a Clinical Stage Biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody based therapeutics for the treatment of cancer. The company annual revenue is 64 million USD and  307 employees as on 2019. The headquarters is in USA.
  6. Zeria Pharmaceutical

    World Rank (Jan-05-2024)
    11,326
    Market Cap (Jan-05-2024)
    0.617 Billion USD
    World Rank (Jul-30-2023)
    10,479
    Market Cap (Jul-30-2023)
    0.726 Billion USD
    World Rank (Dec-25-2022)
    10,000
    Market Cap (Dec-25-2022)
    0.747 Billion USD
    World Rank (Jan-07-2022)
    10,937
    Market Cap (Jan-07-2022)
    0.76 Billion USD
    Annual Revenue in USD
    434 Million USD
    Annual Net Income in USD
    29 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
  7. Novavax

    World Rank (Jan-05-2024)
    11,359
    Market Cap (Jan-05-2024)
    0.613 Billion USD
    World Rank (Jul-30-2023)
    10,617
    Market Cap (Jul-30-2023)
    0.708 Billion USD
    World Rank (Dec-25-2022)
    9,445
    Market Cap (Dec-25-2022)
    0.821 Billion USD
    World Rank (Jan-07-2022)
    1,955
    Market Cap (Jan-07-2022)
    9.58 Billion USD
    Annual Revenue in USD
    1,598 Million USD
    Annual Operating Income in USD
    -664 Million USD
    Annual Net Income in USD
    -657 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Novavax is a Late Stage Biotechnology company that promotes improved global health through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. The company annual revenue is 157.0 million USD and 375 employees as on 2020. The headquarters is in USA.

Share

Ads